Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy

被引:13
|
作者
de Leeuw, N
Melchers, WJG
Balk, AHMM
de Jonge, N
Galama, JMD
机构
[1] Univ Nijmegen Hosp, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Hosp Rotterdam Dijkzigt, Dept Cardiol, Rotterdam, Netherlands
[3] Univ Utrecht Hosp, Dept Cardiol, Utrecht, Netherlands
关键词
D O I
10.1086/598625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microbial persistence may be involved in the pathogenesis of idiopathic dilated cardiomyopathy (IDC). Therefore, we evaluated the role of various cardiopathogenic microorganisms in patients with end-stage IDC. In a previous study, we did not find evidence for the persistence of enterovirus RNA in end-stage IDC. In the present study, we looked for other microorganisms that are frequently associated with heart disease, including cytomegalovirus, hepatitis B virus,hepatitis C virus, Borrelia burgdorferi, Chlamydia species, mycoplasmata, and Toxoplasma gondii. Serology, polymerase chain reaction (PCR) analysis specific for detection of microbial genomic sequences, or both investigations were performed on myocardial samples from 37 patients with end-stage IDC. PCR analysis was performed on multiple myocardial samples per patient Thirty-nine patients with end-stage heart disease of known cause were included as controls. On the basis of our serological data and PCR analyses, we did not find any evidence that microbial persistence in the heart is involved in the end-stage disease process of IDC.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 50 条
  • [1] Frequency of viral persistence in end-stage dilated cardiomyopathy
    Mahon, NG
    Risley, P
    Zal, B
    Baboonian, C
    Davies, MJ
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 166A - 166A
  • [2] Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy:: an innocent bystander?
    Repetto, A
    Dal Bello, B
    Pasotti, M
    Agozzino, M
    Viganò, M
    Klersy, C
    Tavazzi, L
    Arbustini, E
    EUROPEAN HEART JOURNAL, 2005, 26 (15) : 1519 - 1527
  • [3] TREATMENT OF END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    MOORE, CK
    WATERER, HC
    BRITISH HEART JOURNAL, 1994, 72 (06): : S52 - S56
  • [4] Microbial persistence and idiopathic dilated cardiomyopathy - Editorial response
    Lerner, AM
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 526 - 527
  • [5] No evidence for persistent enterovirus infection in cattle with end-stage idiopathic dilated cardiomyopathy
    Nart, P
    Nicolson, L
    Morrison, M
    RESEARCH IN VETERINARY SCIENCE, 2003, 75 (03) : 241 - 244
  • [6] Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy
    Lionetti, Vincenzo
    Matteucci, Marco
    Ribezzo, Marco
    Di Silvestre, Dario
    Brambilla, Francesca
    Agostini, Silvia
    Mauri, Pierluigi
    Padeletti, Luigi
    Pingitore, Alessandro
    Delsedime, Luisa
    Rinaldi, Mauro
    Recchia, Fabio A.
    Pucci, Angela
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (03) : 396 - 414
  • [7] No evidence for persistent enterovirus infection in patients with end-stage idiopathic dilated cardiomyopathy
    de Leeuw, N
    Melchers, WJG
    Balk, AHMM
    de Jonge, N
    Galama, JMD
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01): : 256 - 259
  • [8] Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy
    Dowling, RD
    Koenig, S
    Laureano, MA
    Cerrito, P
    Gray, LA
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1998, 17 (12): : 1208 - 1212
  • [9] NICARDIPINE TESTING IN END-STAGE DILATED IDIOPATHIC CARDIOMYOPATHY WITH PULMONARY-HYPERTENSION
    TAMBURINO, C
    RUSSO, G
    DIPAOLA, R
    GIUFFRIDA, G
    ADVANCES IN THERAPY, 1992, 9 (01) : 46 - 51
  • [10] THE ROLE OF MYOCARDITIS IN END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    TEXAS HEART INSTITUTE JOURNAL, 1987, 14 (03) : 268 - 275